Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2017

Study Completion Date

August 31, 2017

Conditions
Colorectal CancerRectal Bleeding
Interventions
DRUG

Desmopressin

"Dose groups: Group 1: 0.25 µg/kg/day; Group 2: 0.25 µg/kg/12 hours; Group 3: 0.50 µg/kg/12 hours; Group 4: 1 µg/kg/day; Group 5: 1 µg/kg/12 hours; Group 6: 2 µg/kg/day.~All groups will receive desmopressin intravenously, in a 15-20 minutes infusion, one or two times a day. The administration will be repeated 24 hours after the first infusion."

Trial Locations (2)

C1264AAA

Hospital de Gastroenterologia ¨B.Udaondo¨, Ciudad Autonoma de Buenos Aires

Unknown

"Instituto de Oncología Alexander Fleming", Ciudad Autónoma de Buenos Aires

Sponsors
All Listed Sponsors
lead

Laboratorio Elea Phoenix S.A.

INDUSTRY